Yahoo Maps Out Genome Ad Strategy

Rough as the past year has been for Yahoo, one of the company’s more head-scratching moves may yet prove beneficial. Last November, Yahoo snatched up Interclick for $270 million, leaving many in the industry to wonder, what does Yahoo need with yet another ad network?

Yahoo Banks on Its Data With Genome Audience Platform

Headlining Scott Thompson's legacy at Yahoo will probably be the swirl of events that led to his departure after only four months as CEO (though his resume may say otherwise).